Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07GLO
|
||||
| Former ID |
DNC011394
|
||||
| Drug Name |
4-Allyl-6-nitro-2-piperazin-1-yl-quinoline
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [526278] | ||
| Formula |
C16H18N4O2
|
||||
| Canonical SMILES |
C=CCC1=CC(=NC2=C1C=C(C=C2)[N+](=O)[O-])N3CCNCC3
|
||||
| InChI |
1S/C16H18N4O2/c1-2-3-12-10-16(19-8-6-17-7-9-19)18-15-5-4-13(20(21)22)11-14(12)15/h2,4-5,10-11,17H,1,3,6-9H2
|
||||
| InChIKey |
MQKUUUQECTZPIV-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent serotonin transporter | Target Info | Inhibitor | [526278] | |
| KEGG Pathway | Serotonergic synapse | ||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.